Future Science Group platform migration library guide

In December 2023 biomedical publisher Future Science Group joined Taylor & Francis. We are delighted to welcome the addition of 32 peer-reviewed FSG journals, and are looking forward to supporting the authors, editors and readers of these titles. They complement the existing range of over 340 Taylor & Francis medical and healthcare journals.

Joining Taylor & Francis means that there will be changes in how customers access content for Future Science Group. The Future Medicine and Future Science platforms are closing on 24th May 2024. After this point, journals hosted on these platforms will have a new home at Taylor & Francis Online.

To support a smooth transition for you and your library users we have included essential information and steps you need to take to make sure ongoing access to these titles.

Dual hosting and redirects

On 4th April 2024 we start the process of dual hosting on the journals’ current platforms and Taylor & Francis Online. All content up to 2023 is available on Taylor & Francis Online. 2024 journal content will be loaded to both sites up to the point that the Future Science and Future Medicine sites close.

Permanent 301 redirects will be applied at title level from the Future Medicine and Future Science sites to the journals’ new homes on Taylor & Francis Online from 24th May.

Managing an account on Taylor & Francis Online

A nominated person from your institution will need to be registered as an account administrator on Taylor & Francis Online in order to manage your organization’s account.

We have information and support available to help with this: How to register

Checking access is correct

We have been working hard to make sure your access is transferred accurately to Taylor & Francis Online. Please do take some time to check it matches that on Future Medicine and Future Science.

Do we have the right IP range for your institution?

Please do also take some time to check that we have the right IP range for your institution on Taylor & Francis Online.

Support with checking and adding IP addresses is available here: How do I update my institution’s IP ranges?

Usage statistics

Before the platforms close, please download any required usage statistics from Future Medicine and Future Science. Taylor & Francis will retain limited access to usage statistics from these platforms until May 2026 for calendar years 2022-24. This can be provided to on request, but libraries will not be available to self-serve this data after the end of May 2024.

Linking and discovery tools

KBART holding files will be made available to the following vendors: ExLibris – Alma; Summon/360/Intota; SFX; TDNet; Rialto; OCLC. They will also be available for you to download from Taylor & Francis Online. Further support is available here: How do I set up my link resolver?

DOIs and CrossRef linking will point to Taylor & Francis Online from 16th May 2024.

We are also working with Google Scholar to point users to Taylor & Francis Online.

Further help

List of journal titles

Below is a list of the journal titles with information including their new home on Taylor & Francis Online. Please note, the FSG links will close and redirect to Taylor & Francis Online at the end of May 2024.

Journal acronymJournal nameModelFSG linkT&F link
BMMBiomarkers in MedicineHybridhttps://www.futuremedicine.com/journal/bmmhttps://www.tandfonline.com/journals/ibmm20
EPIEpigenomicsHybridhttps://www.futuremedicine.com/journal/epihttps://www.tandfonline.com/journals/iepi20
FCAFuture CardiologyHybridhttps://www.futuremedicine.com/journal/fcahttps://www.tandfonline.com/journals/ifca20
FMBFuture MicrobiologyHybridhttps://www.futuremedicine.com/journal/fmbhttps://www.tandfonline.com/journals/ifmb20
FONFuture OncologyHybridhttps://www.futuremedicine.com/journal/fonhttps://www.tandfonline.com/journals/ifon20
FVLFuture VirologyHybridhttps://www.futuremedicine.com/journal/fvlhttps://www.tandfonline.com/journals/ifvl20
IMTImmunotherapyHybridhttps://www.futuremedicine.com/journal/imthttps://www.tandfonline.com/journals/iimy20
NNMNanomedicineHybridhttps://www.futuremedicine.com/journal/nnmhttps://www.tandfonline.com/journals/innm20
NMTNeurodegenerative Disease ManagementHybridhttps://www.futuremedicine.com/journal/nmthttps://www.tandfonline.com/journals/inmt20
PMTPain ManagementHybridhttps://www.futuremedicine.com/journal/pmthttps://www.tandfonline.com/journals/inmt20
PMEPersonalized MedicineHybridhttps://www.futuremedicine.com/journal/pmehttps://www.tandfonline.com/journals/ipme20
PGSPharmacogenomicsHybridhttps://www.futuremedicine.com/journal/pgshttps://www.tandfonline.com/journals/ipgs20
RMERegenerative MedicineHybridhttps://www.futuremedicine.com/journal/rmehttps://www.tandfonline.com/journals/irme20
FNLFuture NeurologyOAhttps://www.futuremedicine.com/journal/fnlhttps://www.tandfonline.com/journals/ifnl20
CRCColorectal CancerOAhttps://www.futuremedicine.com/journal/crchttps://www.tandfonline.com/journals/icrc20
MMTMelanoma ManagementOAhttps://www.futuremedicine.com/journal/mmthttps://www.tandfonline.com/journals/immt20
LMTLung Cancer ManagementOAhttps://www.futuremedicine.com/journal/lmthttps://www.tandfonline.com/journals/ilmt20
CNSCNS OncologyOAhttps://www.futuremedicine.com/journal/cnshttps://www.tandfonline.com/journals/icns20
HEPHepatic OncologyOAhttps://www.futuremedicine.com/journal/hephttps://www.tandfonline.com/journals/ihep20
IJEInternational Journal of Endocrine Oncology [rename coming]OAhttps://www.futuremedicine.com/journal/ijehttps://www.tandfonline.com/journals/iije20
TDETherapeutic DeliveryHybridhttps://www.future-science.com/journal/tdehttps://www.tandfonline.com/journals/itde20
BIOBioanalysisHybridhttps://www.future-science.com/journal/biohttps://www.tandfonline.com/journals/ibio20
FMCFuture Medicinal ChemistryHybridhttps://www.future-science.com/journal/fmchttps://www.tandfonline.com/journals/ifmc20
PPAPharmaceutical Patent AnalystHybridhttps://www.future-science.com/journal/ppahttps://www.tandfonline.com/journals/ippa20
FDDFuture Drug DiscoveryOAhttps://www.future-science.com/journal/fddhttps://www.tandfonline.com/journals/ifdd20
BTNBioTechniquesOAhttps://www.future-science.com/journal/btnhttps://www.tandfonline.com/journals/ibtn20
FSOAFuture Science OAOAhttps://www.future-science.com/journal/fsoahttps://www.tandfonline.com/journals/ifso20
FRDFuture Rare DiseasesOAhttps://www.futuremedicine.com/journal/frdhttps://www.tandfonline.com/journals/ifrd20

Below is the list of ceasing journals – content from these journals will be available on Taylor & Francis Online.

Information on eBooks

Frequently asked questions